These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11684423)

  • 1. Cheap AIDS drugs for developing countries.
    de Boer J
    Trends Cell Biol; 2001 Nov; 11(11):450. PubMed ID: 11684423
    [No Abstract]   [Full Text] [Related]  

  • 2. Recall of AIDS drug hits world's poorest patients.
    AIDS Read; 2007 Sep; 17(9):439. PubMed ID: 17902224
    [No Abstract]   [Full Text] [Related]  

  • 3. Roche gives in to Brazil over AIDS drug.
    Ahmad K
    Lancet Infect Dis; 2001 Oct; 1(3):138. PubMed ID: 11871484
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethics and AIDS drugs.
    Dowell W
    Time; 1999 Jul; 154(2):49. PubMed ID: 10538646
    [No Abstract]   [Full Text] [Related]  

  • 5. No money, no meds.
    Mabry M
    Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
    [No Abstract]   [Full Text] [Related]  

  • 6. Nelfinavir access in Canada.
    TreatmentUpdate; 1998 Sep; 10(7):6, 8. PubMed ID: 11365783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of genotypic and phenotypic resistance in 2 nelfinavir-experienced patients.
    Bakker A
    J Infect Dis; 2000 May; 181(5):1862-4. PubMed ID: 10823804
    [No Abstract]   [Full Text] [Related]  

  • 8. Cut-rate AIDS.
    Golden F
    Time; 2001 Mar; 157(11):68. PubMed ID: 11276822
    [No Abstract]   [Full Text] [Related]  

  • 9. Nelfinavir (Viracept) price increase 4.6 percent.
    AIDS Treat News; 1998 Oct; (No 305):3-4. PubMed ID: 11365867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bush declines to support drug companies' line on AIDS profits.
    Dickson D
    Nature; 2001 Mar; 410(6824):3. PubMed ID: 11241998
    [No Abstract]   [Full Text] [Related]  

  • 11. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost a major concern with protease inhibitors.
    AIDS Alert; 1996 Apr; 11(4):41-2. PubMed ID: 11363402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experts clash over likely impact of cheap AIDS drugs in Africa.
    Wadman M
    Nature; 2001 Apr; 410(6829):615-6. PubMed ID: 11287906
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 16. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 17. A train wreck on board the Titanic.
    Senak M
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):40-1. PubMed ID: 11363745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thank God for rich women with mustaches.
    Friedman JH
    Med Health R I; 2001 Jul; 84(7):222-3. PubMed ID: 11482273
    [No Abstract]   [Full Text] [Related]  

  • 19. Nelfinavir study recruiting in eight cities.
    AIDS Patient Care STDS; 1996 Dec; 10(6):376. PubMed ID: 11361560
    [No Abstract]   [Full Text] [Related]  

  • 20. Just the medicine. Cheaper AIDS drugs.
    Whitelaw K
    US News World Rep; 2001 Mar; 130(12):31. PubMed ID: 11277041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.